Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing type
4
Filing date
Feb 25, 2021
Updated
Feb 26, 2021 ยท 7:26 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership